- Approval Id
- c729f2d4221546d4
- Drug Name
- TAMOXIFEN TABLET 20 MG
- Product Name
- TAMOXIFEN TABLET 20 MG
- Approval Number
- SIN07094P
- Approval Date
- 1992-07-03
- Registrant
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Licence Holder
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>4.2. Posology and method of administration</strong><br>
For oral administration.</p>
<p><strong>Adults (including elderly)</strong><br>
The dosage range is 20 to 40 mg daily, given either in divided doses twice daily or as a single dose once daily.</p>
<p><strong>Use in children</strong><br>
The use of Tamoxifen is not recommended in children, as safety and efficacy have not been established (see Pharmacodynamic and Pharmacokinetics properties – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>).</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>4.1. Therapeutic indications</strong><br>
Tamoxifen is used for the treatment of breast cancer.</p>
- Contraindications
- <p><strong>4.3. Contraindications</strong><br>
Tamoxifen must not be given during pregnancy. Pre-menopausal patients must be carefully examined before treatment for breast cancer or infertility to exclude the possibility of pregnancy (see section 4.6. – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>).<br>
Tamoxifen should not be given to patients who have experienced hypersensitivity to the product or any of its ingredients.</p>
- Atc Code
- L02BA01
- Atc Item Name
- tamoxifen
- Pharma Manufacturer Name
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
